Gillian Kenny Associates - Hep B Research
Date Added: 13/05/11
We are currently conducting market research interviews with patients who have been diagnosed with Hepatitis B.
Consenting patients will be required to take part in a face to face interview lasting 60 minutes with a qualified interviewer at a time convenient to the patient.
Please, be aware that these interviews will be audio recorded for analysis purposes only
The patient would receive an incentive of £50 for his or her involvement in the study. We would also like to offer you a finder's fee of £30 for
each patient that successfully takes part. Alternatively we can make a
donation to a charity of your choice. If you are interested in helping
I can then provide you with some more information as we have certain
quota's to fulfil.
Patient confidentiality is paramount to GKA, we would, therefore be grateful if you could pass our details (juliesheen@gilliankenny.com) on to any patients that you believe would be suitable to take part rather than passing on their details to us.
We are members of and adhere to MRS, BHBIA and the ESOMAR guidelines,
which are also in-line with the Data Protection Act 1998. Any
information gathered as a result of the interview will be used for
research purposes only and may not be used for any other purpose. The
guidelines clearly state that there can be no attempt to "sell" within
an exercise that has been presented as market research. In addition to
this, all information given will be in complete confidence and names
will not be revealed to any other party. We are now being asked to pass
on to our client details of adverse events that are mentioned during
the course of market research interviews. Should you raise an adverse
event in a specific patient during the discussion we will need to report
this even if it has already been reported by you directly to the
company or regulatory authorities using the MHRA's 'Yellow card' system.
In such a situation you will be asked whether or not you are willing
to waive the confidentiality given to you using the market research
codes of conduct specifically in relation to that adverse event.
Everything else you say during the course of the interview will
continue to remain confidential, and you will still have the option to
remain anonymous if you so wish.
If you have any questions or
would like further information on the study, please, don't hesitate to
contact me on 01594 515 115.
We look forward to hearing from you.
Kind regards,
Julie Sheen